Revenue and Earnings Per Share (EPS) are the heart of the fundamental analysis of a company's worth. The Revenue and EPS Summary provides the Revenue, EPS and Dividends of a company by year and ...

Kenvue products will continue to bear the name Johnson & Johnson and the old logo for the time being – presumably until the old stock is ready to be replaced with its new branding, also designed by ...

Johnson & Johnson management expects operational sales growth between 2.5% and 3.5% in 2025, indicating a strategic focus on consistent mid-point growth. Adjusted operational EPS for 2025 is ...

Adjusted earnings per share (EPS) fell by 9% to $2.42, affected by special charges and acquisition-related costs. The innovative medicine and medtech segments showed solid sales growth.